	貿易債権者		日付
Acadia Pharmaceuticals	USD 10.9M	10.84M	2025-12
Adma Biologics	USD 22.52M	1.5M	2025-12
ALKERMES	USD 107.95M	39.95M	2025-12
Alterity Therapeutics Limited	AUD 1.27M	1.81M	2024-12
AstraZeneca	USD 25.28B	252M	2025-12
BioCryst Pharmaceuticals	USD 15.83M	10.26M	2025-12
Bristol-Myers Squibb	USD 4.29B	1.14B	2025-09
Cipla	INR 30.35B	1.98B	2025-09
Clal Biotechnology	ILS 21.05M	1.62M	2021-12
Compugen	USD 2.35M	6.77M	2025-12
CSL	USD 3.17B	290M	2025-12
Eli Lilly	USD 5.38B	1.12B	2025-12
Esperion Therapeutics	USD 65.07M	12.44M	2025-12
GlaxoSmithKline	GBP 15.38B	294M	2025-12
Grifols	EUR 987.75M	47.87M	2025-12
Halozyme Therapeutics	USD 20.9M	5.54M	2025-12
Ionis Pharmaceuticals	USD 14.33M	8.47M	2025-09
J&J	USD 11.99B	2.37B	2025-12
Merck	USD 4.15B	102M	2025-09
Minerva Neurosciences	USD 640K	305K	2025-12
Neurocrine Biosciences	USD 545.5M	425.6M	2025-12
Novartis	USD 4.46B	99M	2025-12
Novavax	USD 24.58M	9.35M	2025-12
Pfizer	USD 5.02B	142M	2025-09
Roche Holding	CHF 5.78B	1.27B	2025-12
Sanofi	EUR 22.93B	927M	2025-12
Takeda	JPY 467.59B	28.61B	2025-12
Vanda Pharmaceuticals	USD 39.09M	33.28M	2024-12